EyePoint Pharmaceuticals, Inc. — Director's Dealing 2018

Mar 30, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2018-03-28

Reporting Person: Eastman Ronald W (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.001 par value	8273461	Indirect
Common Stock, $0.001 par value	332863	Indirect

Footnotes

F1: These securities are held by EW Healthcare Partners L.P. ("EWHP"). Mr. Eastman is a manager of Essex Woodlands IX, LLC (the "General Partner"), which is the general partner of Essex Woodlands Fund IX-GP, L.P. ("Fund IX-GP"), the general partner that manages EWHP. As manager, Mr. Eastman shares voting and investment powers for EWHP. Mr. Eastman disclaims beneficial ownership of all such securities except to the extent of his pecuniary interest therein.

F2: These securities are held by EW Healthcare Partners-A L.P. ("EWHP-A"). Mr. Eastman is a manager of the General Partner, which is the general partner of Fund IX-GP, the general partner that manages EWHP-A. As manager, Mr. Eastman shares voting and investment powers for EWHP-A. Mr. Eastman disclaims beneficial ownership of all such securities except to the extent of his pecuniary interest therein.